Longevity

Why is everyone talking about Longevity?

Longevity has become one of the most recurring concepts across the fields of health, nutrition and well-being. However, far from being a passing trend, it reflects an extensive demographic, scientific and economic shift that is redefining how we understand prevention, product formulation and ingredient innovation.

Today, talking about longevity means going beyond “living longer” and focusing on how to preserve functionality, autonomy and quality of life over time.

An unprecedented Demographic Shift

According to data from the World Health Organization (WHO) and the United Nations, population ageing is a global, accelerated and structural phenomenon. It is estimated that by 2030, one in six people worldwide will be over the age of 60 and that by 2050, the population in this age group will exceed 2.1 billion. The cohort aged 80 and above will be the fastest-growing segment, tripling to reach 426 million people (1).

This shift is not limited to developed countries. Approximately 80% of the older population will live in low- and middle-income countries, increasing pressure on healthcare systems and reinforcing the need for effective and sustainable long-term preventive strategies (1).

Longevity is not just about living longer, it is about living better

From a scientific perspective, ageing is defined as the progressive accumulation of cellular and molecular damage, leading to a gradual loss of functional capacity and an increased risk of chronic diseases (2).

This process is multifactorial and multisystemic. Key biological mechanisms involved include mitochondrial dysfunction, telomere shortening, cellular senescence associated with the inflammatory SASP phenotype (inflammaging), genomic instability derived from DNA damage, gut dysbiosis and musculoskeletal degeneration, such as sarcopenia and loss of bone density (2–4).

These mechanisms explain why longevity cannot be addressed through a single approach, but rather as a complex process requiring integrated, evidence-based interventions.

 

Figure 1. Key biological mechanisms of ageing. Adapted from López-Otín et al. (2013) and subsequent literature (2–4).

From “Anti-Ageing” to Lifelong Health

Advances in scientific knowledge have driven a paradigm shift. Longevity is no longer viewed solely through the lens of “anti-ageing,” but rather through lifelong health strategies aimed at preserving physical, cognitive and metabolic function for longer periods of life (3,4).

In this context, key areas of scientific and market interest include:

Sources: Rivero-Segura NA et al., Nutrients 2024;16(17):2835; Carvalho BG et al., Nutrition
Research 2025; Chopra AS et al., Pharmacological Research 2022;175:106001.

Longevity and Nutraceuticals:

a strategic Relationship

The relationship between the longevity market and nutraceuticals is close and bidirectional. The longevity market includes products, interventions and technologies designed to extend health span and delay the beginning of age-related diseases. Within this framework, nutraceuticals, defined as bioactive compounds providing benefits beyond basic nutrition, have emerged as one of the leading development categories due to their ability to modulate key processes such as oxidative stress, chronic inflammation and cellular senescence (5–7).

The growth of the nutraceutical market is driven by population ageing, increasing health awareness and the demand for preventive strategies that help maintain functionality and quality of life in later years. A broad range of compounds is currently under investigation for their potential geroprotective effects, meaning their capacity to delay or prevent age-related pathologies (5,8).

However, while promising preclinical and epidemiological data exist, robust clinical evidence in humans remains limited for many ingredients. This underscores the importance of advancing towards formulations based on well-defined mechanisms of action, high-quality clinical studies and clear regulatory frameworks (6).

An Industry in rapid Expansion​

Scientific interest in longevity is also reflected in economic data. Global investment in this sector is growing at double- and triple-digit rates, driven by post-pandemic prevention, the development of health technologies, artificial intelligence and biomarker-based personalisation. For brands and developers, this represents a clear opportunity to innovate with rigour, supported by scientifically validated ingredients, coherent formulations and credible messaging.

Looking ahead

Everyone is talking about longevity because it is no longer a trend, but a biological, demographic and strategic reality. Understanding its scientific foundations is essential to developing solutions that meet the needs of a population that does not simply want to live longer, but to live better.

Longevity is not improvised.

It is built on science, evidence and long-term vision.

Are you looking for the right ingredients?

Subscribe to our newsletter…

Sign up now

…or find our ingredients in the following product portfolio!

Discover our Product Portfolio

References

  1. United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2022: Summary of Results. New York: United Nations; 2022.
  2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. doi:10.1016/j.cell.2013.05.039.
  3. López-Delgado DS, Chapues-Andrade GL, Narváez CA, Santacruz JZ, Rosero-Galindo CY. Physiology of ageing: update and genetic perspective. Medicina de Familia. SEMERGEN. 2025;51(6):102452. doi:10.1016/j.semerg.2025.102452.
  4. Carvalho BG, Ribeiro AA, da Mota JC, Carvalho LM, Nicoletti CF. Integrating biological age, epigenetic clocks and telomere length in precision nutrition strategies for chronic disease management: potential frameworks and ongoing challenges. Nutrition Research. 2025. doi:10.1016/j.nutres.2025.01.004.
  5. Rivero-Segura NA, Zepeda-Arzate EA, Castillo-Vázquez SK, et al. Exploring the geroprotective potential of nutraceuticals. Nutrients. 2024;16(17):2835. doi:10.3390/nu16172835.
  6. Chopra AS, Lordan R, Horbańczuk OK, et al. The current use and evolving landscape of nutraceuticals. Pharmacological Research. 2022;175:106001. doi:10.1016/j.phrs.2021.106001.
  7. Kaur A, Macip S, Stover CM. An appraisal on the value of using nutraceutical-based senolytics and senostatics in aging. Frontiers in Cell and Developmental Biology. 2020;8:218. doi:10.3389/fcell.2020.00218.
  8. Vaiserman A, Lushchak O. Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives. Journal of Translational Medicine. 2017;15(1):160. doi:10.1186/s12967-017-1259-8.